Upgrade to SI Premium - Free Trial

Pfizer (PFE) Reports Collaboration Agreement with BioNTech for Development mRNA-based Vaccines for Prevention of Influenza

August 16, 2018 6:08 AM
BioNTech AG, a rapidly growing biotechnology company focused on precise immunotherapies for the treatment of cancer and infectious disease, today ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA Management Comments

Next Articles